Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Lantheus Holdings, Inc. (LNTH) vs Dr. Reddy's Laboratories Ltd (RDY)

Lantheus Holdings, Inc. and Dr. Reddy's Laboratories Ltd are both Drug Manufacturers Specialty & Generic companies. Dr. Reddy's Laboratories Ltd is the larger, with a market value of $10.0B against $6.5B — 1.5× the size. Lantheus Holdings, Inc. trades at the lower P/E: 23.7× against 30.8×. Lantheus Holdings, Inc. grew revenue faster over the last twelve months: 2.35% against −11.6%. Lantheus Holdings, Inc. has the higher net margin (17.7% vs 9.81%) and the higher return on invested capital (14.7% vs 5.89%). Across the 22 metrics below, Lantheus Holdings, Inc. leads on 15 and Dr. Reddy's Laboratories Ltd on 7.

Valuation

Metric LNTH RDY Drug Manufacturers Specialty & Generic median
P/E 23.69 30.85 20.14
P/S 4.18 2.79 2.25
P/B 4.95 2.35 1.90
Price to free cash flow 16.54 69.03 16.54
EV/EBITDA 16.38 15.92 12.29
EV/Sales 4.16 2.76 2.56
Earnings yield 4.22% 3.24% (2.99%)
Free cash flow yield 6.04% 1.45% 0.00%

Profitability

Metric LNTH RDY Drug Manufacturers Specialty & Generic median
Gross margin 60.14% 50.00% 53.94%
Operating margin 19.43% 10.91% 0.00%
Net margin 17.69% 9.81% 0.00%
Free cash flow margin 25.24% 4.05% 0.00%
Return on equity 22.21% 8.21% (0.40%)
Return on assets 12.15% 5.55% (3.32%)
Return on invested capital 14.65% 5.89% 0.00%

Growth

Metric LNTH RDY Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 2.35% (11.60%) 10.01%
EPS growth (last fiscal year) (21.79%) (30.38%) —
Revenue growth, 5-year CAGR 35.35% 6.66% 6.74%
Net income growth, 5-year CAGR 0.00% 14.08% 0.00%

Health

Metric LNTH RDY Drug Manufacturers Specialty & Generic median
Debt to equity 0.44 0.19 0.05
Current ratio 3.06 1.90 2.31
Net debt to EBITDA 0.55 (0.15) 0.85

Dividend

Metric LNTH RDY Drug Manufacturers Specialty & Generic median
Dividend yield — 0.66% 1.70%
Payout ratio 0.00 0.14 0.00

Size

Metric LNTH RDY Drug Manufacturers Specialty & Generic median
Market cap 6.51b 10.02b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack